|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ABL1-NTRK2 (FusionGDB2 ID:HG25TG4915) |
Fusion Gene Summary for ABL1-NTRK2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ABL1-NTRK2 | Fusion gene ID: hg25tg4915 | Hgene | Tgene | Gene symbol | ABL1 | NTRK2 | Gene ID | 25 | 4915 |
Gene name | ABL proto-oncogene 1, non-receptor tyrosine kinase | neurotrophic receptor tyrosine kinase 2 | |
Synonyms | ABL|BCR-ABL|CHDSKM|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl | EIEE58|GP145-TrkB|OBHD|TRKB|trk-B | |
Cytomap | ('ABL1')('NTRK2') 9q34.12 | 9q21.33 | |
Type of gene | protein-coding | protein-coding | |
Description | tyrosine-protein kinase ABL1ABL protooncogene 1 nonreceptor tyrosine kinaseAbelson tyrosine-protein kinase 1bcr/c-abl oncogene proteinc-abl oncogene 1, receptor tyrosine kinaseproto-oncogene c-Ablproto-oncogene tyrosine-protein kinase ABL1truncated | BDNF/NT-3 growth factors receptorBDNF-tropomyosine receptor kinase Bneurotrophic tyrosine kinase receptor type 2tropomyosin-related kinase Btyrosine kinase receptor B | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | P00519 | Q16620 | |
Ensembl transtripts involved in fusion gene | ENST00000318560, | ||
Fusion gene scores | * DoF score | 21 X 55 X 13=15015 | 10 X 9 X 7=630 |
# samples | 68 | 10 | |
** MAII score | log2(68/15015*10)=-4.46472591830681 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/630*10)=-2.65535182861255 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ABL1 [Title/Abstract] AND NTRK2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ABL1(133710912)-NTRK2(87338487), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | ABL1-NTRK2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ABL1-NTRK2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ABL1-NTRK2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ABL1-NTRK2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ABL1 | GO:0006974 | cellular response to DNA damage stimulus | 15657060 |
Hgene | ABL1 | GO:0006975 | DNA damage induced protein phosphorylation | 18280240 |
Hgene | ABL1 | GO:0018108 | peptidyl-tyrosine phosphorylation | 7590236|9144171|10713049|11121037 |
Hgene | ABL1 | GO:0038083 | peptidyl-tyrosine autophosphorylation | 10518561 |
Hgene | ABL1 | GO:0042770 | signal transduction in response to DNA damage | 9037071|15657060 |
Hgene | ABL1 | GO:0043065 | positive regulation of apoptotic process | 9037071 |
Hgene | ABL1 | GO:0046777 | protein autophosphorylation | 10713049 |
Hgene | ABL1 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 15657060 |
Hgene | ABL1 | GO:0051353 | positive regulation of oxidoreductase activity | 12893824 |
Hgene | ABL1 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity | 20823226 |
Hgene | ABL1 | GO:0070301 | cellular response to hydrogen peroxide | 10713049 |
Hgene | ABL1 | GO:0071103 | DNA conformation change | 9558345 |
Hgene | ABL1 | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 11121037 |
Hgene | ABL1 | GO:1990051 | activation of protein kinase C activity | 10713049 |
Hgene | ABL1 | GO:2001020 | regulation of response to DNA damage stimulus | 9461559 |
Fusion gene breakpoints across ABL1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across NTRK2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ESCA | TCGA-VR-A8EW | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
Top |
Fusion Gene ORF analysis for ABL1-NTRK2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000318560 | ENST00000277120 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
In-frame | ENST00000318560 | ENST00000304053 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
In-frame | ENST00000318560 | ENST00000323115 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
In-frame | ENST00000318560 | ENST00000359847 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
In-frame | ENST00000318560 | ENST00000376208 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
In-frame | ENST00000318560 | ENST00000376213 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
In-frame | ENST00000318560 | ENST00000376214 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
In-frame | ENST00000318560 | ENST00000395866 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
In-frame | ENST00000318560 | ENST00000395882 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000376214 | NTRK2 | chr9 | 87338487 | + | 4547 | 460 | 270 | 2393 | 707 |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000376213 | NTRK2 | chr9 | 87338487 | + | 4499 | 460 | 270 | 2345 | 691 |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000395882 | NTRK2 | chr9 | 87338487 | + | 6438 | 460 | 270 | 1310 | 346 |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000304053 | NTRK2 | chr9 | 87338487 | + | 7620 | 460 | 270 | 1538 | 422 |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000376208 | NTRK2 | chr9 | 87338487 | + | 7572 | 460 | 270 | 1490 | 406 |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000277120 | NTRK2 | chr9 | 87338487 | + | 3451 | 460 | 270 | 2393 | 707 |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000323115 | NTRK2 | chr9 | 87338487 | + | 3232 | 460 | 270 | 2345 | 691 |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000359847 | NTRK2 | chr9 | 87338487 | + | 6434 | 460 | 270 | 1310 | 346 |
ENST00000318560 | ABL1 | chr9 | 133710912 | + | ENST00000395866 | NTRK2 | chr9 | 87338487 | + | 1795 | 460 | 270 | 1310 | 346 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000318560 | ENST00000376214 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.001360544 | 0.9986394 |
ENST00000318560 | ENST00000376213 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.001598528 | 0.99840146 |
ENST00000318560 | ENST00000395882 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.000853147 | 0.9991468 |
ENST00000318560 | ENST00000304053 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.000686133 | 0.99931383 |
ENST00000318560 | ENST00000376208 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.000733911 | 0.9992661 |
ENST00000318560 | ENST00000277120 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.001891209 | 0.99810874 |
ENST00000318560 | ENST00000323115 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.00228449 | 0.9977155 |
ENST00000318560 | ENST00000359847 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.000815442 | 0.99918455 |
ENST00000318560 | ENST00000395866 | ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 0.000670847 | 0.9993292 |
Top |
Fusion Genomic Features for ABL1-NTRK2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 4.11E-05 | 0.999959 |
ABL1 | chr9 | 133710912 | + | NTRK2 | chr9 | 87338487 | + | 4.11E-05 | 0.999959 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ABL1-NTRK2 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:133710912/chr9:87338487) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ABL1 | NTRK2 |
FUNCTION: Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717' (PubMed:28428613). ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-153' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Regulates T-cell differentiation in a TBX21-dependent manner. Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity (By similarity). {ECO:0000250|UniProtKB:P00520, ECO:0000269|PubMed:10391250, ECO:0000269|PubMed:11971963, ECO:0000269|PubMed:12379650, ECO:0000269|PubMed:12531427, ECO:0000269|PubMed:12672821, ECO:0000269|PubMed:15031292, ECO:0000269|PubMed:15556646, ECO:0000269|PubMed:15657060, ECO:0000269|PubMed:15886098, ECO:0000269|PubMed:16424036, ECO:0000269|PubMed:16678104, ECO:0000269|PubMed:16943190, ECO:0000269|PubMed:17306540, ECO:0000269|PubMed:17623672, ECO:0000269|PubMed:18328268, ECO:0000269|PubMed:18945674, ECO:0000269|PubMed:19891780, ECO:0000269|PubMed:20357770, ECO:0000269|PubMed:20417104, ECO:0000269|PubMed:28428613, ECO:0000269|PubMed:9037071, ECO:0000269|PubMed:9144171, ECO:0000269|PubMed:9461559}. | FUNCTION: Receptor tyrosine kinase involved in the development and the maturation of the central and the peripheral nervous systems through regulation of neuron survival, proliferation, migration, differentiation, and synapse formation and plasticity (By similarity). Receptor for BDNF/brain-derived neurotrophic factor and NTF4/neurotrophin-4. Alternatively can also bind NTF3/neurotrophin-3 which is less efficient in activating the receptor but regulates neuron survival through NTRK2 (PubMed:7574684, PubMed:15494731). Upon ligand-binding, undergoes homodimerization, autophosphorylation and activation (PubMed:15494731). Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades. Through SHC1, FRS2, SH2B1, SH2B2 activates the GRB2-Ras-MAPK cascade that regulates for instance neuronal differentiation including neurite outgrowth. Through the same effectors controls the Ras-PI3 kinase-AKT1 signaling cascade that mainly regulates growth and survival. Through PLCG1 and the downstream protein kinase C-regulated pathways controls synaptic plasticity. Thereby, plays a role in learning and memory by regulating both short term synaptic function and long-term potentiation. PLCG1 also leads to NF-Kappa-B activation and the transcription of genes involved in cell survival. Hence, it is able to suppress anoikis, the apoptosis resulting from loss of cell-matrix interactions. May also play a role in neutrophin-dependent calcium signaling in glial cells and mediate communication between neurons and glia. {ECO:0000250|UniProtKB:P15209, ECO:0000269|PubMed:15494731, ECO:0000269|PubMed:7574684}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 18_22 | 26 | 1131.0 | Compositional bias | Note=Poly-Ser |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 197_282 | 194 | 839.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 295_365 | 194 | 839.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 538_807 | 194 | 839.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 197_282 | 194 | 554.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 295_365 | 194 | 554.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 538_807 | 194 | 554.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 197_282 | 194 | 823.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 295_365 | 194 | 823.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 538_807 | 194 | 823.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 197_282 | 194 | 478.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 295_365 | 194 | 478.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 538_807 | 194 | 478.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 197_282 | 194 | 538.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 295_365 | 194 | 538.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 538_807 | 194 | 538.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 197_282 | 194 | 823.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 295_365 | 194 | 823.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 538_807 | 194 | 823.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 197_282 | 194 | 839.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 295_365 | 194 | 839.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 538_807 | 194 | 839.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 148_196 | 38 | 322.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 197_282 | 38 | 322.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 295_365 | 38 | 322.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 538_807 | 38 | 322.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 197_282 | 194 | 478.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 295_365 | 194 | 478.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 538_807 | 194 | 478.0 | Domain | Protein kinase | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 544_552 | 194 | 839.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 544_552 | 194 | 554.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 544_552 | 194 | 823.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 544_552 | 194 | 478.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 544_552 | 194 | 538.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 544_552 | 194 | 823.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 544_552 | 194 | 839.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 544_552 | 38 | 322.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 544_552 | 194 | 478.0 | Nucleotide binding | ATP | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 116_137 | 38 | 322.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 92_113 | 38 | 322.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 455_822 | 194 | 839.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 455_822 | 194 | 554.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 455_822 | 194 | 823.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 455_822 | 194 | 478.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 455_822 | 194 | 538.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 455_822 | 194 | 823.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 455_822 | 194 | 839.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 455_822 | 38 | 322.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 455_822 | 194 | 478.0 | Topological domain | Cytoplasmic | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 431_454 | 194 | 839.0 | Transmembrane | Helical | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 431_454 | 194 | 554.0 | Transmembrane | Helical | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 431_454 | 194 | 823.0 | Transmembrane | Helical | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 431_454 | 194 | 478.0 | Transmembrane | Helical | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 431_454 | 194 | 538.0 | Transmembrane | Helical | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 431_454 | 194 | 823.0 | Transmembrane | Helical | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 431_454 | 194 | 839.0 | Transmembrane | Helical | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 431_454 | 38 | 322.0 | Transmembrane | Helical | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 431_454 | 194 | 478.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 605_609 | 26 | 1131.0 | Compositional bias | Note=Poly-Lys |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 782_1019 | 26 | 1131.0 | Compositional bias | Note=Pro-rich |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 897_903 | 26 | 1131.0 | Compositional bias | Note=Poly-Pro |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 127_217 | 26 | 1131.0 | Domain | SH2 |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 242_493 | 26 | 1131.0 | Domain | Protein kinase |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 61_121 | 26 | 1131.0 | Domain | SH3 |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 1090_1100 | 26 | 1131.0 | Motif | Nuclear export signal |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 381_405 | 26 | 1131.0 | Motif | Note=Kinase activation loop |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 709_715 | 26 | 1131.0 | Motif | Nuclear localization signal 2 |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 762_769 | 26 | 1131.0 | Motif | Nuclear localization signal 3 |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 248_256 | 26 | 1131.0 | Nucleotide binding | Note=ATP |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 316_322 | 26 | 1131.0 | Nucleotide binding | Note=ATP |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 1_60 | 26 | 1131.0 | Region | Note=CAP |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 869_968 | 26 | 1131.0 | Region | DNA-binding |
Hgene | ABL1 | chr9:133710912 | chr9:87338487 | ENST00000318560 | + | 1 | 11 | 953_1130 | 26 | 1131.0 | Region | Note=F-actin-binding |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 148_196 | 194 | 839.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 32_61 | 194 | 839.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 148_196 | 194 | 554.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 32_61 | 194 | 554.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 148_196 | 194 | 823.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 32_61 | 194 | 823.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 148_196 | 194 | 478.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 32_61 | 194 | 478.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 148_196 | 194 | 538.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 32_61 | 194 | 538.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 148_196 | 194 | 823.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 32_61 | 194 | 823.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 148_196 | 194 | 839.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 32_61 | 194 | 839.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 32_61 | 38 | 322.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 148_196 | 194 | 478.0 | Domain | Note=LRRCT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 32_61 | 194 | 478.0 | Domain | Note=LRRNT | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 116_137 | 194 | 839.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 92_113 | 194 | 839.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 116_137 | 194 | 554.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 92_113 | 194 | 554.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 116_137 | 194 | 823.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 92_113 | 194 | 823.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 116_137 | 194 | 478.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 92_113 | 194 | 478.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 116_137 | 194 | 538.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 92_113 | 194 | 538.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 116_137 | 194 | 823.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 92_113 | 194 | 823.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 116_137 | 194 | 839.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 92_113 | 194 | 839.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 116_137 | 194 | 478.0 | Repeat | Note=LRR 2 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 92_113 | 194 | 478.0 | Repeat | Note=LRR 1 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 32_430 | 194 | 839.0 | Topological domain | Extracellular | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 32_430 | 194 | 554.0 | Topological domain | Extracellular | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 32_430 | 194 | 823.0 | Topological domain | Extracellular | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 32_430 | 194 | 478.0 | Topological domain | Extracellular | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 32_430 | 194 | 538.0 | Topological domain | Extracellular | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 32_430 | 194 | 823.0 | Topological domain | Extracellular | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 32_430 | 194 | 839.0 | Topological domain | Extracellular | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 32_430 | 38 | 322.0 | Topological domain | Extracellular | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 32_430 | 194 | 478.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for ABL1-NTRK2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>490_490_1_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000277120_length(transcript)=3451nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGATTTCTCATGGTTTGGATTTGGGAAAGTAAAATCAAGACAAGGTGTTGGCCCAGCCTCCGTTATCAGCAATGATGAT GACTCTGCCAGCCCACTCCATCACATCTCCAATGGGAGTAACACTCCATCTTCTTCGGAAGGTGGCCCAGATGCTGTCATTATTGGAATG ACCAAGATCCCTGTCATTGAAAATCCCCAGTACTTTGGCATCACCAACAGTCAGCTCAAGCCAGACACATTTGTTCAGCACATCAAGCGA CATAACATTGTTCTGAAAAGGGAGCTAGGCGAAGGAGCCTTTGGAAAAGTGTTCCTAGCTGAATGCTATAACCTCTGTCCTGAGCAGGAC AAGATCTTGGTGGCAGTGAAGACCCTGAAGGATGCCAGTGACAATGCACGCAAGGACTTCCACCGTGAGGCCGAGCTCCTGACCAACCTC CAGCATGAGCACATCGTCAAGTTCTATGGCGTCTGCGTGGAGGGCGACCCCCTCATCATGGTCTTTGAGTACATGAAGCATGGGGACCTC AACAAGTTCCTCAGGGCACACGGCCCTGATGCCGTGCTGATGGCTGAGGGCAACCCGCCCACGGAACTGACGCAGTCGCAGATGCTGCAT ATAGCCCAGCAGATCGCCGCGGGCATGGTCTACCTGGCGTCCCAGCACTTCGTGCACCGCGATTTGGCCACCAGGAACTGCCTGGTCGGG GAGAACTTGCTGGTGAAAATCGGGGACTTTGGGATGTCCCGGGACGTGTACAGCACTGACTACTACAGGGTCGGTGGCCACACAATGCTG CCCATTCGCTGGATGCCTCCAGAGAGCATCATGTACAGGAAATTCACGACGGAAAGCGACGTCTGGAGCCTGGGGGTCGTGTTGTGGGAG ATTTTCACCTATGGCAAACAGCCCTGGTACCAGCTGTCAAACAATGAGGTGATAGAGTGTATCACTCAGGGCCGAGTCCTGCAGCGACCC CGCACGTGCCCCCAGGAGGTGTATGAGCTGATGCTGGGGTGCTGGCAGCGAGAGCCCCACATGAGGAAGAACATCAAGGGCATCCATACC CTCCTTCAGAACTTGGCCAAGGCATCTCCGGTCTACCTGGACATTCTAGGCTAGGGCCCTTTTCCCCAGACCGATCCTTCCCAACGTACT CCTCAGACGGGCTGAGAGGATGAACATCTTTTAACTGCCGCTGGAGGCCACCAAGCTGCTCTCCTTCACTCTGACAGTATTAACATCAAA GACTCCGAGAAGCTCTCGAGGGAAGCAGTGTGTACTTCTTCATCCATAGACACAGTATTGACTTCTTTTTGGCATTATCTCTTTCTCTCT TTCCATCTCCCTTGGTTGTTCCTTTTTCTTTTTTTAAATTTTCTTTTTCTTTTTTTTTTCGTCTTCCCTGCTTCACGATTCTTACCCTTT CTTTTGAATCAATCTGGCTTCTGCATTACTATTAACTCTGCATAGACAAAGGCCTTAACAAACGTAATTTGTTATATCAGCAGACACTCC AGTTTGCCCACCACAACTAACAATGCCTTGTTGTATTCCTGCCTTTGATGTGGATGAAAAAAAGGGAAAACAAATATTTCACTTAAACTT TGTCACTTCTGCTGTACAGATATCGAGAGTTTCTATGGATTCACTTCTATTTATTTATTATTATTACTGTTCTTATTGTTTTTGGATGGC TTAAGCCTGTGTATAAAAAAGAAAACTTGTGTTCAATCTGTGAAGCCTTTATCTATGGGAGATTAAAACCAGAGAGAAAGAAGATTTATT ATGAACCGCAATATGGGAGGAACAAAGACAACCACTGGGATCAGCTGGTGTCAGTCCCTACTTAGGAAATACTCAGCAACTGTTAGCTGG GAAGAATGTATTCGGCACCTTCCCCTGAGGACCTTTCTGAGGAGTAAAAAGACTACTGGCCTCTGTGCCATGGATGATTCTTTTCCCATC ACCAGAAATGATAGCGTGCAGTAGAGAGCAAAGATGGCTTCCGTGAGACACAAGATGGCGCATAGTGTGCTCGGACACAGTTTTGTCTTC GTAGGTTGTGATGATAGCACTGGTTTGTTTCTCAAGCGCTATCCACAGAACCTTTGTCAACTTCAGTTGAAAAGAGGTGGATTCATGTCC >490_490_1_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000277120_length(amino acids)=707AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG TAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKDFSWFGFGKVKSRQGVGPASVISNDD DSASPLHHISNGSNTPSSSEGGPDAVIIGMTKIPVIENPQYFGITNSQLKPDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQD KILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE -------------------------------------------------------------- >490_490_2_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000304053_length(transcript)=7620nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGATTTCTCATGGTTTGGATTTGGGAAAGTAAAATCAAGACAAGGTGTTGGCCCAGCCTCCGTTATCAGCAATGATGAT GACTCTGCCAGCCCACTCCATCACATCTCCAATGGGAGTAACACTCCATCTTCTTCGGAAGGTGGCCCAGATGCTGTCATTATTGGAATG ACCAAGATCCCTGTCATTGAAAATCCCCAGTACTTTGGCATCACCAACAGTCAGCTCAAGCCAGACACATGGCCCAGAGGTTCCCCCAAG ACCGCCTGATAATAATTTGGTATTTGGAGGCTCCTGTGTCACTGCAGGAACTAAAGGAGGCTAAATCCATGCCTGATGGAGGAGAAGAGT TCTATGGTTATCTGCAAATTCTGGCCAGACAACATCTTGACGTCACTCCTTAGCTTCCATAACCTAGCCAAGCAAGAAGTTGCCTTTCCA AGACAAAGCAGTGTGCTCTAATGACTAACCCCTCAAAGTACTATGCCACTTTAACTATAGACCCATCTCCTCGATCAATCAGGATGGCAA GATGGAGCTGAGGAGCTCAGCAACATCAAGTCTGGAGTTGGTCTTTAACTCAACTAGCTCGTTTAGACGTGTCTGAACACCACATCACCT GACAGCACGGGGTGGTTTCCCAGTAAAATTTACAAACTCAGCTCAAGGGCAGCTGTGTTGCTTTCCTTTCCTTGACTGCTGAGAAACTTT TTGACAGGGAACAATGGAAACACACCTTCTGAGCTGAAACAAACAAACAGAAACAAAACATACTAACCAGCAAAATCCCCAAATCATCAA TCTTGGGTTCTCTTGAAGGGCAGGAGTGTGTTTTATCTTCTCCCGTCGGAGCAAACACTATAGATGTCCTCCCTAAAATTCTGTCTTCCC TAGAGCAGCCTTGTAAATTAGCTAGGGTCCTAGGGTTGAGGCCTAAATCAACTTAAAATTGTCTCTAAATATGTACCTGGATGTGTTTGT ACTTGCAGAGCATGCCCTCTTCATGTGCCTAGGGCTAGTAACTCCCTGTGGCAGAGGCATGTAAAGTATTCTGACTTTTTTTTTTTCAAC TTAATTCCATTTCCAATGAAATGGATTTTTAAAAATTTTCTCCAGAGTGTGCCATACTTCTCCAGCTATTATAGTTAATGTGTGTGTATC CTTGTGTATATGTGTGTTTGTGTGTGCATATGTGTTTTCCTAGTGGTTACATGCTTACTAGGCAATTATGTAAATAAGCACAGATTCATA GGCCAGCTAGGCCTGAGGAAAGAAGACATTATAAAGGGAGGGAGTATTTTAACATTAGCTAAAGCTATCACACAAGGCACCCATTCTGCT CCCCTCAACAGCCACAGCCCACTTCGTCCTTGTCTTACCAATAAGGGGAAAGGCTGGAGGTGATATTTTTCACAGAACCGCAGAGGTTTT GAACATATTTGCAACATTACTTTGAGTACACATGAGCAAAAATTCTGAATTACATCCAGGACCCCAGAAGCTCATTAGATCAAAGAGTGC GGGGCCCCTCAGAGTTACCAGAGATTATCTGCAGACTTCAGTGCAATCGAATGACCATGGTCCATTTTGATGGTCAGAGGTAGGACTGAA AAACGGGTAGAAACAATTGCTTTAGCGCTTCCTTCTGTACTTTGCCTATTAATGTTTTGTCTTTCAAAAATATATTTTCTCCTAATTGTT TAATTGGCCAAATAATGGCTGCTTTGGGAGTTGTTTGTATGCCTTGGAAGGCCATGGCCTGCACTTTAAAAATAAGCTAAGTCCATTCTG CCCAGCACGAGCATTAGGACAGAGAATGCACTTATTTTAGGATCCTTAAAAATTGCTTCTTTTATGGCACACTGGGTTGACGACTCATCT CGTGGGAGCCTTCATGGCACATTGCTGCTGTTCTGCAGGTCCCAATACAATTCCTTCCCCCTCTCAGTGCCACGGCCCCCCCATTGCTAG CTACAACAATTTGATATCATATTCCCTTTTCAACTCCAAAGGAGATGATAAGAAGCTATCAAATAATGCTTTAAAAAAGCAACTTGAGTT TCTTAAAAGAAAGGAAATGAATACATGCTGCATAATTACATTTAAAATGTAAGCCATGTTATTATAAGCCGCACTGAGATGAAGATTTGT TAGCAAACCAGTTTCAAGCACACTCACAGTGAAGTAAAATCATGTTTTTAGCATCTGACCATTGGGTAATATTATTCTTTGTTATCAAAA GAGAAATATCACCCAAGTATAGTATACTTAGACCTCCTAGAGGAAACACTCCAGTCCTAAGCTTGGTGTCTGAAAAGAAAAACAAAAATA AAGATTATGGATTTAGGTCAGGGAGACAGAGTGATATTCTGAAGACTGTGTTTACTCCCTCATCATCGGCCAACCAAGATGGAGTTCTGC ATCCTGCACATATCAGACATTTCAGTCCAATTTCACCAAAGCATCAGTGATGTTCTAGAAGCATCCCAGCAGATGGAGGATCCTAATGTA TTTGTTCTGGGTATTTCCCAAGGCCCAGCCTGACTGGAGTGTGTGTACCAACAGGATGAATCCAATCAAGCTACGCCCCCATTTTGGTTT CGGATTGGCCACTCTTGCATGTGCTAGTAGATTGTGGACCAGGACCAGCTGAGCAAACACAGTTGCAGAGTAGCCTCCTATGTTGCTAAG AAGCTCCTGCTACCCAGGTGCTTTGAACAATTGAGTGCTCCCTCTGGTTAAGTAGAGATGGCACCACCGGAGTTTTTCTTGGATGTGAGG CTCAATCCTTTACGGCAGCTATTATAACAAAGTGAAGGTTTTCTCCCTGGGAAATGCAGCTTTTCTCTGTCTTTACTAATTCTGCCAGCC TGTGAGAGTAACCACCGTAGCTGGGCTTCTTCTCAGATTAATTGTCATGCCAGGTCTCCTTCCTGGGGAGCTGTGATGCTGCTCTGAGGT TGATTGCTGAGGTTGTAGTGGGTTTTTGTTTGTTTTTGTTTAGTTTTTCTTGATTGTTCTTCTTTCTCTTGAATGGCAAGAGAAGAAACA CTTTCTCTAACCCACGGCCAGGAAGGAAATGGGGAGAGAGCTACTTCTTAGTTCAACCTGGTTGCCACATAAAGGAATCTCTCTCCTTGG ACTCAGCCCCTAACTGGAAGCAAGAGCCACTGCCCTCTGAGACTGAGAGAGCAGCCCGAGGAGGAGATGAATCCATTCTGCCCTTTGTTT GGGTTTGCTTCCTGTCAGTGAGAGAATGCTGAGGCAGTTCCTGTTATGTGAAACTTTCATTTTTAAAACCAGGACAGTCCTAAACAGACT GGAATGAGTTGGTCAATCCCAGTTGGTATAGGCCCAATGATTTTTGCTAGTAAGATAGGATTGTCTTCCTCACCCAAAATGCCTTCAAGT GCCCTAAAATGGGTATTTTAAAATAAGAATAAATAATGTAGATTTAGTAGAAAACCTGGAAAACATAAGAAACAAAGATGAAACGAAAAG TCCCATGTAATTCCACCAGTTAGAGTTAACCACTGATATCGTTTGGATATATGGCTTTCTAGTCTTGTGGATATCCTTTTAATCTCTTGT AATATAAAGTCTGACCATATGTGTCCTTGCATTTGTTTGTACTGGACTCTGTTAATATTTCTATAGTAATGGCTCACTTTGGGGAGATTG TGCTGCACAGTGTGTAGGAAGCACATTGGGTGTATTATTCCCAGTTTTGTATTTTGTATTTCCTTGGAGATGTGCAGGGGTTAAGAGCGG GGGTCTGGCCATAGCTGGCCACGTCAGACTCTCATATGGTAAGTATCACAGAGCACATGAGGCCTGTGTTATGCGCTGGAAAGACTCAGG AAATGAGAGGCTCTCTTGTTCTGACAAGGCAGGCTGAGAGCTCTCATTTAGGGTCATCACTCCAGATAACTCCAAATGCAGTTTATTGCT CAACTGAAGCAGATGATCACTTTTTGCCTCCAAGTTCTTCACCCTAGCTAGCTCCTTTCAAAGAGCCGAGTATGCTGGATCTTAAAGGGC CAAACTAGTTACATCTCATACATTTCCTGATGTTTAGGGATGCCTTCACTTCCATCAAGGATACCTTGGCTGTGCAAGGACCTCTGATAG CTGGAGTCTCCTTTTGGTCACTCCCAGCTTTGCTTAAACTTGATGGAGTTTGCTGTCCAGTGATCCCCGGATCTTTCATCATGAAAGCCT TCCTTCCTCTCCTGATGTCTCAGGCCTCTAGACCTAGACTGGGGTTCTGGCAAGGAGGCCTCTATCAATAGTATGACATCCAATAATATG TTAGTGTTGATATTTTGCACAGTAATATTAAGTTTAAGAGATTATAAAAATGAGTTCAAATGAATAAGTTCCTGTGATGTAAGAGATTAG ATATGTGTGATTTCAGAACCAAAGGCAGGGGGGAATCCCAGAAAGAAAACAATAATATAATCCTAGTTTCTATATATTATTTTTATTCAT TACTGTATATGGGTAGAGATCAATATTCTTTCTTATGCTGTTACTATTAATTAACACATTTTTTAACCATGCCATTGAACTTTTGGGTGC ATTAAAGTGGAACCCAAGCTCCTCATTAGATAATAATGGCATTTGGACTGAGTGCCATATTCCTAAATTTCCAATAAAGTGGTTGATATA GAGAGGACAGGATAAAGCCCTATAGTGTGCAGTTATATCAAAACAGCTAGTCTCCACTTTAGGGAATGCCTTTACTAGAGATTACATGAA ATGTCTGCTTATAAAATAAGCAGAGATGGCACCACTAAGCAGCCACCTGAATTGTTTTCCTACAGGAATGATTACTTTTCAGATCCATTT ATGTTTTCATGCTCAATACTTACTCCCCTTCCCTGCAACACCCAAAGAGTTTACTTTTGCAAGTCATTTGGTCTTCAGTCTACTACTGAG GAATAGAGAGGCACTAACTGCTTTACCCAGGATCAGAACTCATGTTCTTACCTTCTATTAATAGAGTACTTGAGCCAGATGGACTAACTG GTCTCACATTTTCTCTATCTTGGTTTTACTTCCATAAACATCAATATCTTTACCCACATGATTTTTCCATCCTCCCATTTTTTTCCATAT GTATTAGGGTTCAGGAACTATGATGCTAATGATCACATTTCTTCCTAGTTCCTAATTTCATTAGTGCCATTTCCTGATATCTACAGAAAC AATTATCAATACATGTAGCTGCTTGAGCCTTATTTAGAAGGCTAGCCTTTCTTTTCCAAGTGCTGTCAGAATGTATACATTTAGTCTGTC TTTTTCCCTTTTAGGAGTCTTTGTTCTGGGTTGATGGCAAAATTCCTCTTTTTACATGTGAGATTTTTGATTTCACTGAATTCTACCTAG ATTTTTATGGACATTGGATTTTAAAGAGGAAAACACTCATTTTCTTAGTAAGATATTGGTGATACATAGCTATGCCATTGATTTCCATAC TCCTGAGCTTTGGGGAGGGAGACAGTGGCCAAGTAGCAGGCAGAATAAGATCATCACTCATGTCCTGAATCAATCACACTTTCCTTCTCG GATTGTGTATATGCTCTGCCACTTCCTACATATTACATCCTGAGTTTTTAAGTAAAGTGGATCTTAGCCAGATTTGAGTCTAATGGCTGA TTCATCGGCATAGTTCTTGGCGTTAACATCTCAGTGTCCTCTTTAGTTCTCTTTGAGGATTCATGTCATTGAGGGCCTTTGTGCCTCCAC TTGTCTCAGTATGAGGAAGAACTTTGGTGTGAGGGCGGAGCTATGTGAAGGGTTGCTGGGTTGGGGGATTAGTTCATATGGTCCCCATGC CATCTATTTACTTTTGGAGAGAGGGGACTTTGAGTGGGTGGGTATGGATAGATGTTCCTCAAGGAAACCCTGCTGGCTAATGGGCACTAC ATCTGTGTATTACTGTGATTCTCTCTGTAAGCTCCCCATGTGGCCAAGGACCCCCCTCCTACCAGGGCACTTCCTGCCACCTCATTGCAC TGGTCTCAACCATTCAGCCTGCTGCTGCTGCACCATGTTGGGCTGCGGTAGGATAGGGAAGGGGTTCTGTTGATTGCTAAATGTTGCCTA ACTTTATTTCCCTCTCCCACATTTCATGCAAGGGAGCGGACCTAACACATGACTTGCATTCTCTTCCTATGTTCAGAAACTCCAGGGCTT GCCCACGTGTATGTATGAGTGACCAATGGAGCTTGGAATTCTTTATCTATATGATCTGTCCGAAAATGAGATCTTTTGTACTGGAATTTG >490_490_2_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000304053_length(amino acids)=422AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG TAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKDFSWFGFGKVKSRQGVGPASVISNDD -------------------------------------------------------------- >490_490_3_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000323115_length(transcript)=3232nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGGCCCAGCCTCCGTTATCAGCAATGATGATGACTCTGCCAGCCCACTCCATCACATCTCCAATGGGAGTAACACTCCA TCTTCTTCGGAAGGTGGCCCAGATGCTGTCATTATTGGAATGACCAAGATCCCTGTCATTGAAAATCCCCAGTACTTTGGCATCACCAAC AGTCAGCTCAAGCCAGACACATTTGTTCAGCACATCAAGCGACATAACATTGTTCTGAAAAGGGAGCTAGGCGAAGGAGCCTTTGGAAAA GTGTTCCTAGCTGAATGCTATAACCTCTGTCCTGAGCAGGACAAGATCTTGGTGGCAGTGAAGACCCTGAAGGATGCCAGTGACAATGCA CGCAAGGACTTCCACCGTGAGGCCGAGCTCCTGACCAACCTCCAGCATGAGCACATCGTCAAGTTCTATGGCGTCTGCGTGGAGGGCGAC CCCCTCATCATGGTCTTTGAGTACATGAAGCATGGGGACCTCAACAAGTTCCTCAGGGCACACGGCCCTGATGCCGTGCTGATGGCTGAG GGCAACCCGCCCACGGAACTGACGCAGTCGCAGATGCTGCATATAGCCCAGCAGATCGCCGCGGGCATGGTCTACCTGGCGTCCCAGCAC TTCGTGCACCGCGATTTGGCCACCAGGAACTGCCTGGTCGGGGAGAACTTGCTGGTGAAAATCGGGGACTTTGGGATGTCCCGGGACGTG TACAGCACTGACTACTACAGGGTCGGTGGCCACACAATGCTGCCCATTCGCTGGATGCCTCCAGAGAGCATCATGTACAGGAAATTCACG ACGGAAAGCGACGTCTGGAGCCTGGGGGTCGTGTTGTGGGAGATTTTCACCTATGGCAAACAGCCCTGGTACCAGCTGTCAAACAATGAG GTGATAGAGTGTATCACTCAGGGCCGAGTCCTGCAGCGACCCCGCACGTGCCCCCAGGAGGTGTATGAGCTGATGCTGGGGTGCTGGCAG CGAGAGCCCCACATGAGGAAGAACATCAAGGGCATCCATACCCTCCTTCAGAACTTGGCCAAGGCATCTCCGGTCTACCTGGACATTCTA GGCTAGGGCCCTTTTCCCCAGACCGATCCTTCCCAACGTACTCCTCAGACGGGCTGAGAGGATGAACATCTTTTAACTGCCGCTGGAGGC CACCAAGCTGCTCTCCTTCACTCTGACAGTATTAACATCAAAGACTCCGAGAAGCTCTCGAGGGAAGCAGTGTGTACTTCTTCATCCATA GACACAGTATTGACTTCTTTTTGGCATTATCTCTTTCTCTCTTTCCATCTCCCTTGGTTGTTCCTTTTTCTTTTTTTAAATTTTCTTTTT CTTTTTTTTTTCGTCTTCCCTGCTTCACGATTCTTACCCTTTCTTTTGAATCAATCTGGCTTCTGCATTACTATTAACTCTGCATAGACA AAGGCCTTAACAAACGTAATTTGTTATATCAGCAGACACTCCAGTTTGCCCACCACAACTAACAATGCCTTGTTGTATTCCTGCCTTTGA TGTGGATGAAAAAAAGGGAAAACAAATATTTCACTTAAACTTTGTCACTTCTGCTGTACAGATATCGAGAGTTTCTATGGATTCACTTCT ATTTATTTATTATTATTACTGTTCTTATTGTTTTTGGATGGCTTAAGCCTGTGTATAAAAAAGAAAACTTGTGTTCAATCTGTGAAGCCT TTATCTATGGGAGATTAAAACCAGAGAGAAAGAAGATTTATTATGAACCGCAATATGGGAGGAACAAAGACAACCACTGGGATCAGCTGG TGTCAGTCCCTACTTAGGAAATACTCAGCAACTGTTAGCTGGGAAGAATGTATTCGGCACCTTCCCCTGAGGACCTTTCTGAGGAGTAAA >490_490_3_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000323115_length(amino acids)=691AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG TAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKGPASVISNDDDSASPLHHISNGSNTP SSSEGGPDAVIIGMTKIPVIENPQYFGITNSQLKPDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE -------------------------------------------------------------- >490_490_4_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000359847_length(transcript)=6434nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGGTTTTGTTTTGTTTCATAAGATCCCACTGGATGGGTAGCTGAAATAAAGGAAAAGACAGAGAAAGGGGCTGTGGTGC TTGTTGGTTGATGCTGCCATGTAAGCTGGACTCCTGGGACTGCTGTTGGCTTATCCCGGGAAGTGCTGCTTATCTGGGGTTTTCTGGTAG ATGTGGGCGGTGTTTGGAGGCTGTACTATATGAAGCCTGCATATACTGTGAGCTGTGATTGGGGAACACCAATGCAGAGGTAACTCTCAG GCAGCTAAGCAGCACCTCAAGAAAACATGTTAAATTAATGCTTCTCTTCTTACAGTAGTTCAAATACAAAACTGAAATGAAATCCCATTG GATTGTACTTCTCTTCTGAAAAGTGTGCTTTTTGACCCTACTGGACATTTATTGACTTAATTGCTTCTGTTTATTAAAATTGACCTGCAA AGTTAAAAAAAAATTAAAGTTGAGAACAGGTATAAGTGCACACTGAATAGTCTAATCTACATGTAACACATATTTTAGTGTGATTTTCTA TACTCTAATCAGCACTGAATTCAGAGGGTTTGACTTTTTCATCTATAACACAGTGACTAAAAGAGTTAAGGGTATATATACCATCACTTT GGGACTTGGTAGTATTATTAAAAGGTTATTTCCTTCACTGTCAATAAAAGTCCAAATGTTTAGCTTAGGTCTGAGAGTCAAACAATGTTA AGGATTGTCTTAAAGTTCCTTAGCCAGCAAAACAAAACAAAACAAAACAAACAAATGAAAAACGTTTAAAAAGAAGAAGAAGAAAAAAAA CAAGAACAAGCAGCAACAGCTGTTTTGTTGGGGCTATAGATTTAAGTTAGGCATAGTCAATTTCAGAATAACTAAGAGTGGAATATATGC ATATGGTGAAATTATAACCTTGCCCTTTTTTATTTGCCCTCTGCGATCCACCTGCTTTTTAGAAGTCTGCCGAGTGAGAAGGCCACAGTA TCTCATGCTGTTTGCATTACAGAACTGCAGCTTTTCTACTCTGAAAAGGCCTGGGAGCAGAATGGCTGGCCTGCTGTGAGCAGGAGAGGA GATTCTAAGAAGGATAGTCCCCCCTACAACATACTGTCATACTGCTGGGTTTTCATGGGTAGGAAAGCTTGTCCTGACCCCAGCAGCAAA GAGGTGGCAGGTCGCTAATGAATATATGCTTTATAATGTCCTTCTTCATTGCTGAGAGGGCAGCCTTAGAGCTGTGGATTTCTGCATCCC CCCTGAGTCTGACCCATGGACACCTGTTTCATTCACTTTAGCATCACAGTGACCTTTGTATGCTCTGTTCAGTCTGTGTCAGGCAGTATG CTTGTCCTGAAGAGAGGTTTGGCTATCCCCACCCCACCCCACCCCACCCTGTTCCTTTTTTATCAGGAGGACTTCAGAGCCAGGCCTGCA GCATTTTGTTTGAAAACACAATCAGCTCTGACAGTTAGACATGCACACAGACGCCATAGCTGGATTGGAAACATTGATGTTTTAAAAATT TATTTTTTTTGGAAATAGTTGCACAAATGCTGCAATTTAGCTTTAAGGTTCTATAGATTTTTAACTAGTCCAACACAGTCAGAAACATTG TTTTGAATCCTCTGTAAACCAAGGCATTAATCTTAATAAACCAGGATCCATTTAGGTACCACTTGATATAAAAAGGATATCCATAATGAA TATTTTATACTGCATCCTTTACATTAGCCACTAAATACGTTATTGCTTGATGAAGACCTTTCACAGAATCCTATGGATTGCAGCATTTCA CTTGGCTACTTCATACCCATGCCTTAAAGAGGGGCAGTTTCTCAAAAGCAGAAACATGCCGCCAGTTCTCAAGTTTTCCTCCTAACTCCA TTTGAATGTAAGGGCAGCTGGCCCCCAATGTGGGGAGGTCCGAACATTTTCTGAATTCCCATTTTCTTGTTCGCGGCTAAATGACAGTTT CTGTCATTACTTAGATTCCGATCTTTCCCAAAGGTGTTGATTTACAAAGAGGCCAGCTAATAGCAGAAATCATGACCCTGAAAGAGAGAT GAAATTCAAGCTGTGAGCCAGGCAGGAGCTCAGTATGGCAAAGGTTCTTGAGAATCAGCCATTTGGTACAAAAAAGATTTTTAAAGCTTT TATGTTATACCATGGAGCCATAGAAAGGCTATGGATTGTTTAAGAACTATTTTAAAGTGTTCCAGACCCAAAAAGGAAAAATAAAAAAAA AGGAATATTTGTACCCAACAGCTAGAAGGATTGCAAGGTAGATTTTTGTTTTAAAATGGAGAGAAGTGGACAGATAAGGCCATTTAATAT ATCAAAGATCAGTTGACATCTCCTAGGGAATGATGAAAACAGCAGGCTATTAGAAAATTATTTCATATAGTTCTCGTGTTCTTTTCTTTT TTTTAATCCCTGAAGGGATGATCAGTAACATAGCTTCTCTTTTCTGTACTCTAGACCACCCCTTTTCATCATTTTGCTTTTTATGTCTCC CATAAGAAATGTGCTTTTTAGAGCTTCCTAATGCATGTGTTGCATTATTGCAGCATTAGAAAAGGAGAGGTAGCATTTTTGCTGAAATCG GGCCTGTCACTCTCCAATAAAGGTTCTGGCACTTCAATGCCAGGCAGGTCTCCTAAATGAACAGAATGATCTGTGTGAGCCGATGCCTGC CCTTCCAGAGGGGCCACTGTCCCCAGCCGCAGCCAACTGTGTCCCACAGGAATGGGAGCCTAGGTTTCCAAATCTTGTGATTCTTTAGGA GAAACATGAAACCTGGATTTCGTGTGAAATGTCCCGATTGTTAAAAAGTTGGCTCAATTATTTTTAAAACATTTTGTAAGCCAACAAAAG TCTGTGGGCTGCCAGTTTATTACTTTTGTCTTAAAACATGATCATTGTTCTCTCACGGTATCCTTCTGTCTTCCCGTTGCAAATTCACTT TTCTTTCTTCCTGACATTGCCATTGAGGGCTTTGTTACCACAAGCTAAGAAACTGAGTTTAACAGCCCAGTTATCTGCAACATGTCAATT ACCTTTGCTCCTCTCCTGTGATTCCCACCATGCTGTGACCCTCAGCTGTCTCCCTTTGCTGGGAATTCTGCACCAATGTCTCCCCTCAAC CCATTCCCTGGTTGGTCCTACTCCCGTGTGGCCAGAGACATCCTAGCAAATCCTTCCTCCTATTATATCTGACACTAATTTCTTTTCAAC AGCGCTCATGTCTCTTGGCCCAGTCAGGTGCTGCCAGGTTTAGATAGGAAAGTACATGTCCCATTTTCATGGGTGCCCTTAATGTGGTCC ACGTCCTATATCTTATTATATTTACTCATGGCTCAATGGGGGCCTCCAGAGACCCTCTCAGGCTGCTGAGCTAGACTAAGGAATGCATCC ACCGTCATCACATGAGACACTGACTCTGTGACGACAAAAGTACAAACAGTCTGAGGCTAAGAAAGGTTCATCTCACAACAGGAAAAACAA ATCTCAACACACATTAGAGATAATTGATTCAGGGGTTTTCTCTCCCAGTCTCCCAGCAGGGACTGATTTCATTTCTGACCCACTAGGTTT TCTTTCCAGAAATAGGTAGCAAGGACAAGAACTAAACAATCCCAGCCCCACCCAGCAACACAGAACACAGGAGTTTGCTTTTGGCTTCTC ACTCTCCAAGTAACCCTGAATTAGGCCCAGAATGGCTGAGGCTTGGAGCATCTCCTCAGACAGAGCAGAGGCGACACCTCTTCAGGGGTG TGTGGAGTAAATAGCTCGAAGAGCTGAAGACAGAAAACCAGTTTCACGCCAGGTGCGAGAGAGAGCATAATGGAGGGAAGCCCGCTTTCT CTCTCCTCTTCTTTTCTCTTTATTTCTTTAGAGCACTTGACTTTTTTTTCTCTCTCTCTCTAGTATTCTAAACTGACCCCATGACCAACT GAGAATTTATTTTTGTTTCATTGGTTGTTTCACAGAATTAGAACACACACGACTTTTTATTCCTCCATTGCAAAATGGAATCAAGATACT ACACAAGACCTGTGCTTTCTTCCTTTGCATGATTTACACCTCCGCCTGTTTTGGTGCTAGCTGTCTAGAACTTCTCTCTTGGTTTGAATC TGATTCCTTCACACTACACTAGAAGTTTATTTCATCTTGTTTTGTCTAGACTCCAGATACAGAGGGACAGCTGGACTGAGGACAAGCAAT TCCATCTAGCATAGGGTCTCTCAGGGTTGGTGCATCCAGCCACATGGGCAGGGCCAGTCACATCTAGTCTATGTCCCCAGAGCCCTTGGA GTTGCGCAGCTTAGCTGACTTGACTCCAAGGAAATTAGTACAGAAGTAACCACTCTATTAAGTGTGTTCTGCTATGTTCACATGCCTGTA GTACCTGCAAACCATGCCAGGTTCATCTAAAGACATAGGGGAAGATTAAGGACTCTTTTGGACAGACCATGAATTGAATTTGCTGCCAGG TGCTGCCAGACTGAATTTGGCTGACAGAACTCCCAGCCCAGGAAAGTTCCATGACAATGACTGTCGCAGAAGGAAATTTCCCACTAAAGT CAGTCCATTTTCAAGTTTTGGTCTTCAGAGACAAAAGAACGTCCCAGCCACCTGATTTTGATGGTGAGGTAACTCTAAGTTGAATTCAGG CTAGTGTTGCAGTATAGCTTTGGCATGTTCATGAGTGAGCACCCAGAATGTGTTGAACCAACCCCCACCCCTAACTACTGACTATGACTG CAGTGGGTTTTTATGGGGAAAAAAAGTGTGAAAAGCAAAAAGAAAGGAACAGAGATTTTTTATCACCTTTATTGTAAGACAGTCCATTTA TGAATTGAGTATAAACACATACAAAGTAACAAGAGATTCCTAAGAAACGCAAATCCTTGAGTTTCACGCACTTCATGTTCAACCATTTGC TGTAATCCAGAGGCAGCCTGTGAATCATTCTCATGCCCTGTTTTTTTTTTTTTTTTCCTATAATGTTCTGGGTTTAAAAGCCATCTTTTC CACATTTTCTGTAAATAATGGATAATCATTTTAAAAATTTTTATTTTTAGTGCTGTTTTAACAATGTAGATAGATCATAAATGTACTTGC >490_490_4_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000359847_length(amino acids)=346AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG -------------------------------------------------------------- >490_490_5_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000376208_length(transcript)=7572nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGGCCCAGCCTCCGTTATCAGCAATGATGATGACTCTGCCAGCCCACTCCATCACATCTCCAATGGGAGTAACACTCCA TCTTCTTCGGAAGGTGGCCCAGATGCTGTCATTATTGGAATGACCAAGATCCCTGTCATTGAAAATCCCCAGTACTTTGGCATCACCAAC AGTCAGCTCAAGCCAGACACATGGCCCAGAGGTTCCCCCAAGACCGCCTGATAATAATTTGGTATTTGGAGGCTCCTGTGTCACTGCAGG AACTAAAGGAGGCTAAATCCATGCCTGATGGAGGAGAAGAGTTCTATGGTTATCTGCAAATTCTGGCCAGACAACATCTTGACGTCACTC CTTAGCTTCCATAACCTAGCCAAGCAAGAAGTTGCCTTTCCAAGACAAAGCAGTGTGCTCTAATGACTAACCCCTCAAAGTACTATGCCA CTTTAACTATAGACCCATCTCCTCGATCAATCAGGATGGCAAGATGGAGCTGAGGAGCTCAGCAACATCAAGTCTGGAGTTGGTCTTTAA CTCAACTAGCTCGTTTAGACGTGTCTGAACACCACATCACCTGACAGCACGGGGTGGTTTCCCAGTAAAATTTACAAACTCAGCTCAAGG GCAGCTGTGTTGCTTTCCTTTCCTTGACTGCTGAGAAACTTTTTGACAGGGAACAATGGAAACACACCTTCTGAGCTGAAACAAACAAAC AGAAACAAAACATACTAACCAGCAAAATCCCCAAATCATCAATCTTGGGTTCTCTTGAAGGGCAGGAGTGTGTTTTATCTTCTCCCGTCG GAGCAAACACTATAGATGTCCTCCCTAAAATTCTGTCTTCCCTAGAGCAGCCTTGTAAATTAGCTAGGGTCCTAGGGTTGAGGCCTAAAT CAACTTAAAATTGTCTCTAAATATGTACCTGGATGTGTTTGTACTTGCAGAGCATGCCCTCTTCATGTGCCTAGGGCTAGTAACTCCCTG TGGCAGAGGCATGTAAAGTATTCTGACTTTTTTTTTTTCAACTTAATTCCATTTCCAATGAAATGGATTTTTAAAAATTTTCTCCAGAGT GTGCCATACTTCTCCAGCTATTATAGTTAATGTGTGTGTATCCTTGTGTATATGTGTGTTTGTGTGTGCATATGTGTTTTCCTAGTGGTT ACATGCTTACTAGGCAATTATGTAAATAAGCACAGATTCATAGGCCAGCTAGGCCTGAGGAAAGAAGACATTATAAAGGGAGGGAGTATT TTAACATTAGCTAAAGCTATCACACAAGGCACCCATTCTGCTCCCCTCAACAGCCACAGCCCACTTCGTCCTTGTCTTACCAATAAGGGG AAAGGCTGGAGGTGATATTTTTCACAGAACCGCAGAGGTTTTGAACATATTTGCAACATTACTTTGAGTACACATGAGCAAAAATTCTGA ATTACATCCAGGACCCCAGAAGCTCATTAGATCAAAGAGTGCGGGGCCCCTCAGAGTTACCAGAGATTATCTGCAGACTTCAGTGCAATC GAATGACCATGGTCCATTTTGATGGTCAGAGGTAGGACTGAAAAACGGGTAGAAACAATTGCTTTAGCGCTTCCTTCTGTACTTTGCCTA TTAATGTTTTGTCTTTCAAAAATATATTTTCTCCTAATTGTTTAATTGGCCAAATAATGGCTGCTTTGGGAGTTGTTTGTATGCCTTGGA AGGCCATGGCCTGCACTTTAAAAATAAGCTAAGTCCATTCTGCCCAGCACGAGCATTAGGACAGAGAATGCACTTATTTTAGGATCCTTA AAAATTGCTTCTTTTATGGCACACTGGGTTGACGACTCATCTCGTGGGAGCCTTCATGGCACATTGCTGCTGTTCTGCAGGTCCCAATAC AATTCCTTCCCCCTCTCAGTGCCACGGCCCCCCCATTGCTAGCTACAACAATTTGATATCATATTCCCTTTTCAACTCCAAAGGAGATGA TAAGAAGCTATCAAATAATGCTTTAAAAAAGCAACTTGAGTTTCTTAAAAGAAAGGAAATGAATACATGCTGCATAATTACATTTAAAAT GTAAGCCATGTTATTATAAGCCGCACTGAGATGAAGATTTGTTAGCAAACCAGTTTCAAGCACACTCACAGTGAAGTAAAATCATGTTTT TAGCATCTGACCATTGGGTAATATTATTCTTTGTTATCAAAAGAGAAATATCACCCAAGTATAGTATACTTAGACCTCCTAGAGGAAACA CTCCAGTCCTAAGCTTGGTGTCTGAAAAGAAAAACAAAAATAAAGATTATGGATTTAGGTCAGGGAGACAGAGTGATATTCTGAAGACTG TGTTTACTCCCTCATCATCGGCCAACCAAGATGGAGTTCTGCATCCTGCACATATCAGACATTTCAGTCCAATTTCACCAAAGCATCAGT GATGTTCTAGAAGCATCCCAGCAGATGGAGGATCCTAATGTATTTGTTCTGGGTATTTCCCAAGGCCCAGCCTGACTGGAGTGTGTGTAC CAACAGGATGAATCCAATCAAGCTACGCCCCCATTTTGGTTTCGGATTGGCCACTCTTGCATGTGCTAGTAGATTGTGGACCAGGACCAG CTGAGCAAACACAGTTGCAGAGTAGCCTCCTATGTTGCTAAGAAGCTCCTGCTACCCAGGTGCTTTGAACAATTGAGTGCTCCCTCTGGT TAAGTAGAGATGGCACCACCGGAGTTTTTCTTGGATGTGAGGCTCAATCCTTTACGGCAGCTATTATAACAAAGTGAAGGTTTTCTCCCT GGGAAATGCAGCTTTTCTCTGTCTTTACTAATTCTGCCAGCCTGTGAGAGTAACCACCGTAGCTGGGCTTCTTCTCAGATTAATTGTCAT GCCAGGTCTCCTTCCTGGGGAGCTGTGATGCTGCTCTGAGGTTGATTGCTGAGGTTGTAGTGGGTTTTTGTTTGTTTTTGTTTAGTTTTT CTTGATTGTTCTTCTTTCTCTTGAATGGCAAGAGAAGAAACACTTTCTCTAACCCACGGCCAGGAAGGAAATGGGGAGAGAGCTACTTCT TAGTTCAACCTGGTTGCCACATAAAGGAATCTCTCTCCTTGGACTCAGCCCCTAACTGGAAGCAAGAGCCACTGCCCTCTGAGACTGAGA GAGCAGCCCGAGGAGGAGATGAATCCATTCTGCCCTTTGTTTGGGTTTGCTTCCTGTCAGTGAGAGAATGCTGAGGCAGTTCCTGTTATG TGAAACTTTCATTTTTAAAACCAGGACAGTCCTAAACAGACTGGAATGAGTTGGTCAATCCCAGTTGGTATAGGCCCAATGATTTTTGCT AGTAAGATAGGATTGTCTTCCTCACCCAAAATGCCTTCAAGTGCCCTAAAATGGGTATTTTAAAATAAGAATAAATAATGTAGATTTAGT AGAAAACCTGGAAAACATAAGAAACAAAGATGAAACGAAAAGTCCCATGTAATTCCACCAGTTAGAGTTAACCACTGATATCGTTTGGAT ATATGGCTTTCTAGTCTTGTGGATATCCTTTTAATCTCTTGTAATATAAAGTCTGACCATATGTGTCCTTGCATTTGTTTGTACTGGACT CTGTTAATATTTCTATAGTAATGGCTCACTTTGGGGAGATTGTGCTGCACAGTGTGTAGGAAGCACATTGGGTGTATTATTCCCAGTTTT GTATTTTGTATTTCCTTGGAGATGTGCAGGGGTTAAGAGCGGGGGTCTGGCCATAGCTGGCCACGTCAGACTCTCATATGGTAAGTATCA CAGAGCACATGAGGCCTGTGTTATGCGCTGGAAAGACTCAGGAAATGAGAGGCTCTCTTGTTCTGACAAGGCAGGCTGAGAGCTCTCATT TAGGGTCATCACTCCAGATAACTCCAAATGCAGTTTATTGCTCAACTGAAGCAGATGATCACTTTTTGCCTCCAAGTTCTTCACCCTAGC TAGCTCCTTTCAAAGAGCCGAGTATGCTGGATCTTAAAGGGCCAAACTAGTTACATCTCATACATTTCCTGATGTTTAGGGATGCCTTCA CTTCCATCAAGGATACCTTGGCTGTGCAAGGACCTCTGATAGCTGGAGTCTCCTTTTGGTCACTCCCAGCTTTGCTTAAACTTGATGGAG TTTGCTGTCCAGTGATCCCCGGATCTTTCATCATGAAAGCCTTCCTTCCTCTCCTGATGTCTCAGGCCTCTAGACCTAGACTGGGGTTCT GGCAAGGAGGCCTCTATCAATAGTATGACATCCAATAATATGTTAGTGTTGATATTTTGCACAGTAATATTAAGTTTAAGAGATTATAAA AATGAGTTCAAATGAATAAGTTCCTGTGATGTAAGAGATTAGATATGTGTGATTTCAGAACCAAAGGCAGGGGGGAATCCCAGAAAGAAA ACAATAATATAATCCTAGTTTCTATATATTATTTTTATTCATTACTGTATATGGGTAGAGATCAATATTCTTTCTTATGCTGTTACTATT AATTAACACATTTTTTAACCATGCCATTGAACTTTTGGGTGCATTAAAGTGGAACCCAAGCTCCTCATTAGATAATAATGGCATTTGGAC TGAGTGCCATATTCCTAAATTTCCAATAAAGTGGTTGATATAGAGAGGACAGGATAAAGCCCTATAGTGTGCAGTTATATCAAAACAGCT AGTCTCCACTTTAGGGAATGCCTTTACTAGAGATTACATGAAATGTCTGCTTATAAAATAAGCAGAGATGGCACCACTAAGCAGCCACCT GAATTGTTTTCCTACAGGAATGATTACTTTTCAGATCCATTTATGTTTTCATGCTCAATACTTACTCCCCTTCCCTGCAACACCCAAAGA GTTTACTTTTGCAAGTCATTTGGTCTTCAGTCTACTACTGAGGAATAGAGAGGCACTAACTGCTTTACCCAGGATCAGAACTCATGTTCT TACCTTCTATTAATAGAGTACTTGAGCCAGATGGACTAACTGGTCTCACATTTTCTCTATCTTGGTTTTACTTCCATAAACATCAATATC TTTACCCACATGATTTTTCCATCCTCCCATTTTTTTCCATATGTATTAGGGTTCAGGAACTATGATGCTAATGATCACATTTCTTCCTAG TTCCTAATTTCATTAGTGCCATTTCCTGATATCTACAGAAACAATTATCAATACATGTAGCTGCTTGAGCCTTATTTAGAAGGCTAGCCT TTCTTTTCCAAGTGCTGTCAGAATGTATACATTTAGTCTGTCTTTTTCCCTTTTAGGAGTCTTTGTTCTGGGTTGATGGCAAAATTCCTC TTTTTACATGTGAGATTTTTGATTTCACTGAATTCTACCTAGATTTTTATGGACATTGGATTTTAAAGAGGAAAACACTCATTTTCTTAG TAAGATATTGGTGATACATAGCTATGCCATTGATTTCCATACTCCTGAGCTTTGGGGAGGGAGACAGTGGCCAAGTAGCAGGCAGAATAA GATCATCACTCATGTCCTGAATCAATCACACTTTCCTTCTCGGATTGTGTATATGCTCTGCCACTTCCTACATATTACATCCTGAGTTTT TAAGTAAAGTGGATCTTAGCCAGATTTGAGTCTAATGGCTGATTCATCGGCATAGTTCTTGGCGTTAACATCTCAGTGTCCTCTTTAGTT CTCTTTGAGGATTCATGTCATTGAGGGCCTTTGTGCCTCCACTTGTCTCAGTATGAGGAAGAACTTTGGTGTGAGGGCGGAGCTATGTGA AGGGTTGCTGGGTTGGGGGATTAGTTCATATGGTCCCCATGCCATCTATTTACTTTTGGAGAGAGGGGACTTTGAGTGGGTGGGTATGGA TAGATGTTCCTCAAGGAAACCCTGCTGGCTAATGGGCACTACATCTGTGTATTACTGTGATTCTCTCTGTAAGCTCCCCATGTGGCCAAG GACCCCCCTCCTACCAGGGCACTTCCTGCCACCTCATTGCACTGGTCTCAACCATTCAGCCTGCTGCTGCTGCACCATGTTGGGCTGCGG TAGGATAGGGAAGGGGTTCTGTTGATTGCTAAATGTTGCCTAACTTTATTTCCCTCTCCCACATTTCATGCAAGGGAGCGGACCTAACAC ATGACTTGCATTCTCTTCCTATGTTCAGAAACTCCAGGGCTTGCCCACGTGTATGTATGAGTGACCAATGGAGCTTGGAATTCTTTATCT ATATGATCTGTCCGAAAATGAGATCTTTTGTACTGGAATTTGTGATGTAGTTGATCATTCAGAGCCAAACGCATATACCAATAAAGACAA >490_490_5_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000376208_length(amino acids)=406AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG TAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKGPASVISNDDDSASPLHHISNGSNTP -------------------------------------------------------------- >490_490_6_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000376213_length(transcript)=4499nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGGCCCAGCCTCCGTTATCAGCAATGATGATGACTCTGCCAGCCCACTCCATCACATCTCCAATGGGAGTAACACTCCA TCTTCTTCGGAAGGTGGCCCAGATGCTGTCATTATTGGAATGACCAAGATCCCTGTCATTGAAAATCCCCAGTACTTTGGCATCACCAAC AGTCAGCTCAAGCCAGACACATTTGTTCAGCACATCAAGCGACATAACATTGTTCTGAAAAGGGAGCTAGGCGAAGGAGCCTTTGGAAAA GTGTTCCTAGCTGAATGCTATAACCTCTGTCCTGAGCAGGACAAGATCTTGGTGGCAGTGAAGACCCTGAAGGATGCCAGTGACAATGCA CGCAAGGACTTCCACCGTGAGGCCGAGCTCCTGACCAACCTCCAGCATGAGCACATCGTCAAGTTCTATGGCGTCTGCGTGGAGGGCGAC CCCCTCATCATGGTCTTTGAGTACATGAAGCATGGGGACCTCAACAAGTTCCTCAGGGCACACGGCCCTGATGCCGTGCTGATGGCTGAG GGCAACCCGCCCACGGAACTGACGCAGTCGCAGATGCTGCATATAGCCCAGCAGATCGCCGCGGGCATGGTCTACCTGGCGTCCCAGCAC TTCGTGCACCGCGATTTGGCCACCAGGAACTGCCTGGTCGGGGAGAACTTGCTGGTGAAAATCGGGGACTTTGGGATGTCCCGGGACGTG TACAGCACTGACTACTACAGGGTCGGTGGCCACACAATGCTGCCCATTCGCTGGATGCCTCCAGAGAGCATCATGTACAGGAAATTCACG ACGGAAAGCGACGTCTGGAGCCTGGGGGTCGTGTTGTGGGAGATTTTCACCTATGGCAAACAGCCCTGGTACCAGCTGTCAAACAATGAG GTGATAGAGTGTATCACTCAGGGCCGAGTCCTGCAGCGACCCCGCACGTGCCCCCAGGAGGTGTATGAGCTGATGCTGGGGTGCTGGCAG CGAGAGCCCCACATGAGGAAGAACATCAAGGGCATCCATACCCTCCTTCAGAACTTGGCCAAGGCATCTCCGGTCTACCTGGACATTCTA GGCTAGGGCCCTTTTCCCCAGACCGATCCTTCCCAACGTACTCCTCAGACGGGCTGAGAGGATGAACATCTTTTAACTGCCGCTGGAGGC CACCAAGCTGCTCTCCTTCACTCTGACAGTATTAACATCAAAGACTCCGAGAAGCTCTCGAGGGAAGCAGTGTGTACTTCTTCATCCATA GACACAGTATTGACTTCTTTTTGGCATTATCTCTTTCTCTCTTTCCATCTCCCTTGGTTGTTCCTTTTTCTTTTTTTAAATTTTCTTTTT CTTTTTTTTTTCGTCTTCCCTGCTTCACGATTCTTACCCTTTCTTTTGAATCAATCTGGCTTCTGCATTACTATTAACTCTGCATAGACA AAGGCCTTAACAAACGTAATTTGTTATATCAGCAGACACTCCAGTTTGCCCACCACAACTAACAATGCCTTGTTGTATTCCTGCCTTTGA TGTGGATGAAAAAAAGGGAAAACAAATATTTCACTTAAACTTTGTCACTTCTGCTGTACAGATATCGAGAGTTTCTATGGATTCACTTCT ATTTATTTATTATTATTACTGTTCTTATTGTTTTTGGATGGCTTAAGCCTGTGTATAAAAAAGAAAACTTGTGTTCAATCTGTGAAGCCT TTATCTATGGGAGATTAAAACCAGAGAGAAAGAAGATTTATTATGAACCGCAATATGGGAGGAACAAAGACAACCACTGGGATCAGCTGG TGTCAGTCCCTACTTAGGAAATACTCAGCAACTGTTAGCTGGGAAGAATGTATTCGGCACCTTCCCCTGAGGACCTTTCTGAGGAGTAAA AAGACTACTGGCCTCTGTGCCATGGATGATTCTTTTCCCATCACCAGAAATGATAGCGTGCAGTAGAGAGCAAAGATGGCTTCCGTGAGA CACAAGATGGCGCATAGTGTGCTCGGACACAGTTTTGTCTTCGTAGGTTGTGATGATAGCACTGGTTTGTTTCTCAAGCGCTATCCACAG AACCTTTGTCAACTTCAGTTGAAAAGAGGTGGATTCATGTCCAGAGCTCATTTCGGGGTCAGGTGGGAAAGCCAAGAACTTGGAAAAGAT AAGACAAGCTATAAATTCGGAGGCAAGTTTCTTTTACAATGAACTTTTCAGATCTCACTTCCCTCCGACCCCTAACTTCCATGCCCACCC GTCCTTTTAACTGTGCAAGCAAAATTGTGCATGGTCTTCGTCGATTAATACCTTGTGTGCAGACACTACTGCTCCAGACGTCGTTTCCCT GATAGGTAGAGCAGATCCATAAAAAGGTATGACTTATACAATTAGGGGAAGCTAATGGAGTTTATTAGCTGAGTATCAATGTCTCTGCGT TGTACGGTGGTGATGGGTTTTAATGAATATGGACCCTGAAGCCTGGAAATCCTCATCCACGTCGAACCCACAGGACTGTGGGAAGGGCAG AATCAATCCCTAAGGGAAAGGAAACCTCACCCTGAGGGCATCACATGCACTCATGTTCAGTGTACACAGGTCAAGTCCCTTGCTCTGGGC TCTAGTTGGGAGAGTGGTTTCATTCCAAGTGTACTCCATTGTCAGTATGCTGTTTTTGTTTCCTTCACTCCATTCAAAAAGTCAAAATAC AAAATTTGGCACAGCATGCCAACGGGAGGCTGTGCCCAGACCAAGCACTGGAAGTGTGCTTCTAGGCATAGTCATTGGTTTTGCAAAAAG AGGGCTCAAATTTAAATAGAAATTTACAGCTATTTGAATGGTCAGATATACCAAGAAAGAAAAATATTTCTGTTCCTCAAGAAAACTTGC TACCCTCTGTGAGGGGAATTTTGCTAAACTTGACATCTTTATAACATGAGCCAGATTGAAAGGGAGTGATTTTCATTCATCTTAGGTCAT GTTATTTCATATTTGTTTCTGAAGGTGCGATAGCTCTGTTTTAGGTTTTGCTTGCGCCTGTTAATTACTGGAACACCTTATTTTTCATTA AAGGCTTTGAAAGCCAATTCTCAAAAATTCAAAAGTGCAAATTAACAGAACAAAAGGAAATCCAGTAGCAACTGCAGTCAAGCGAGGGAG >490_490_6_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000376213_length(amino acids)=691AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG TAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKGPASVISNDDDSASPLHHISNGSNTP SSSEGGPDAVIIGMTKIPVIENPQYFGITNSQLKPDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE -------------------------------------------------------------- >490_490_7_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000376214_length(transcript)=4547nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGATTTCTCATGGTTTGGATTTGGGAAAGTAAAATCAAGACAAGGTGTTGGCCCAGCCTCCGTTATCAGCAATGATGAT GACTCTGCCAGCCCACTCCATCACATCTCCAATGGGAGTAACACTCCATCTTCTTCGGAAGGTGGCCCAGATGCTGTCATTATTGGAATG ACCAAGATCCCTGTCATTGAAAATCCCCAGTACTTTGGCATCACCAACAGTCAGCTCAAGCCAGACACATTTGTTCAGCACATCAAGCGA CATAACATTGTTCTGAAAAGGGAGCTAGGCGAAGGAGCCTTTGGAAAAGTGTTCCTAGCTGAATGCTATAACCTCTGTCCTGAGCAGGAC AAGATCTTGGTGGCAGTGAAGACCCTGAAGGATGCCAGTGACAATGCACGCAAGGACTTCCACCGTGAGGCCGAGCTCCTGACCAACCTC CAGCATGAGCACATCGTCAAGTTCTATGGCGTCTGCGTGGAGGGCGACCCCCTCATCATGGTCTTTGAGTACATGAAGCATGGGGACCTC AACAAGTTCCTCAGGGCACACGGCCCTGATGCCGTGCTGATGGCTGAGGGCAACCCGCCCACGGAACTGACGCAGTCGCAGATGCTGCAT ATAGCCCAGCAGATCGCCGCGGGCATGGTCTACCTGGCGTCCCAGCACTTCGTGCACCGCGATTTGGCCACCAGGAACTGCCTGGTCGGG GAGAACTTGCTGGTGAAAATCGGGGACTTTGGGATGTCCCGGGACGTGTACAGCACTGACTACTACAGGGTCGGTGGCCACACAATGCTG CCCATTCGCTGGATGCCTCCAGAGAGCATCATGTACAGGAAATTCACGACGGAAAGCGACGTCTGGAGCCTGGGGGTCGTGTTGTGGGAG ATTTTCACCTATGGCAAACAGCCCTGGTACCAGCTGTCAAACAATGAGGTGATAGAGTGTATCACTCAGGGCCGAGTCCTGCAGCGACCC CGCACGTGCCCCCAGGAGGTGTATGAGCTGATGCTGGGGTGCTGGCAGCGAGAGCCCCACATGAGGAAGAACATCAAGGGCATCCATACC CTCCTTCAGAACTTGGCCAAGGCATCTCCGGTCTACCTGGACATTCTAGGCTAGGGCCCTTTTCCCCAGACCGATCCTTCCCAACGTACT CCTCAGACGGGCTGAGAGGATGAACATCTTTTAACTGCCGCTGGAGGCCACCAAGCTGCTCTCCTTCACTCTGACAGTATTAACATCAAA GACTCCGAGAAGCTCTCGAGGGAAGCAGTGTGTACTTCTTCATCCATAGACACAGTATTGACTTCTTTTTGGCATTATCTCTTTCTCTCT TTCCATCTCCCTTGGTTGTTCCTTTTTCTTTTTTTAAATTTTCTTTTTCTTTTTTTTTTCGTCTTCCCTGCTTCACGATTCTTACCCTTT CTTTTGAATCAATCTGGCTTCTGCATTACTATTAACTCTGCATAGACAAAGGCCTTAACAAACGTAATTTGTTATATCAGCAGACACTCC AGTTTGCCCACCACAACTAACAATGCCTTGTTGTATTCCTGCCTTTGATGTGGATGAAAAAAAGGGAAAACAAATATTTCACTTAAACTT TGTCACTTCTGCTGTACAGATATCGAGAGTTTCTATGGATTCACTTCTATTTATTTATTATTATTACTGTTCTTATTGTTTTTGGATGGC TTAAGCCTGTGTATAAAAAAGAAAACTTGTGTTCAATCTGTGAAGCCTTTATCTATGGGAGATTAAAACCAGAGAGAAAGAAGATTTATT ATGAACCGCAATATGGGAGGAACAAAGACAACCACTGGGATCAGCTGGTGTCAGTCCCTACTTAGGAAATACTCAGCAACTGTTAGCTGG GAAGAATGTATTCGGCACCTTCCCCTGAGGACCTTTCTGAGGAGTAAAAAGACTACTGGCCTCTGTGCCATGGATGATTCTTTTCCCATC ACCAGAAATGATAGCGTGCAGTAGAGAGCAAAGATGGCTTCCGTGAGACACAAGATGGCGCATAGTGTGCTCGGACACAGTTTTGTCTTC GTAGGTTGTGATGATAGCACTGGTTTGTTTCTCAAGCGCTATCCACAGAACCTTTGTCAACTTCAGTTGAAAAGAGGTGGATTCATGTCC AGAGCTCATTTCGGGGTCAGGTGGGAAAGCCAAGAACTTGGAAAAGATAAGACAAGCTATAAATTCGGAGGCAAGTTTCTTTTACAATGA ACTTTTCAGATCTCACTTCCCTCCGACCCCTAACTTCCATGCCCACCCGTCCTTTTAACTGTGCAAGCAAAATTGTGCATGGTCTTCGTC GATTAATACCTTGTGTGCAGACACTACTGCTCCAGACGTCGTTTCCCTGATAGGTAGAGCAGATCCATAAAAAGGTATGACTTATACAAT TAGGGGAAGCTAATGGAGTTTATTAGCTGAGTATCAATGTCTCTGCGTTGTACGGTGGTGATGGGTTTTAATGAATATGGACCCTGAAGC CTGGAAATCCTCATCCACGTCGAACCCACAGGACTGTGGGAAGGGCAGAATCAATCCCTAAGGGAAAGGAAACCTCACCCTGAGGGCATC ACATGCACTCATGTTCAGTGTACACAGGTCAAGTCCCTTGCTCTGGGCTCTAGTTGGGAGAGTGGTTTCATTCCAAGTGTACTCCATTGT CAGTATGCTGTTTTTGTTTCCTTCACTCCATTCAAAAAGTCAAAATACAAAATTTGGCACAGCATGCCAACGGGAGGCTGTGCCCAGACC AAGCACTGGAAGTGTGCTTCTAGGCATAGTCATTGGTTTTGCAAAAAGAGGGCTCAAATTTAAATAGAAATTTACAGCTATTTGAATGGT CAGATATACCAAGAAAGAAAAATATTTCTGTTCCTCAAGAAAACTTGCTACCCTCTGTGAGGGGAATTTTGCTAAACTTGACATCTTTAT AACATGAGCCAGATTGAAAGGGAGTGATTTTCATTCATCTTAGGTCATGTTATTTCATATTTGTTTCTGAAGGTGCGATAGCTCTGTTTT AGGTTTTGCTTGCGCCTGTTAATTACTGGAACACCTTATTTTTCATTAAAGGCTTTGAAAGCCAATTCTCAAAAATTCAAAAGTGCAAAT TAACAGAACAAAAGGAAATCCAGTAGCAACTGCAGTCAAGCGAGGGAGTTGACAAGATAAACCTTACGTCCATTCAAGTTATATGCTGGC >490_490_7_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000376214_length(amino acids)=707AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG TAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKDFSWFGFGKVKSRQGVGPASVISNDD DSASPLHHISNGSNTPSSSEGGPDAVIIGMTKIPVIENPQYFGITNSQLKPDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQD KILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE -------------------------------------------------------------- >490_490_8_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000395866_length(transcript)=1795nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGGTTTTGTTTTGTTTCATAAGATCCCACTGGATGGGTAGCTGAAATAAAGGAAAAGACAGAGAAAGGGGCTGTGGTGC TTGTTGGTTGATGCTGCCATGTAAGCTGGACTCCTGGGACTGCTGTTGGCTTATCCCGGGAAGTGCTGCTTATCTGGGGTTTTCTGGTAG ATGTGGGCGGTGTTTGGAGGCTGTACTATATGAAGCCTGCATATACTGTGAGCTGTGATTGGGGAACACCAATGCAGAGGTAACTCTCAG GCAGCTAAGCAGCACCTCAAGAAAACATGTTAAATTAATGCTTCTCTTCTTACAGTAGTTCAAATACAAAACTGAAATGAAATCCCATTG GATTGTACTTCTCTTCTGAAAAGTGTGCTTTTTGACCCTACTGGACATTTATTGACTTAATTGCTTCTGTTTATTAAAATTGACCTGCAA >490_490_8_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000395866_length(amino acids)=346AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG -------------------------------------------------------------- >490_490_9_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000395882_length(transcript)=6438nt_BP=460nt GGCCTTCCCCCTGCGAGGATCGCCATTGGCCCGGGTTGGCTTTGGAAAGCGGCGGTGGCTTTGGGCCGGGCTCGGCCTCGGGAACGCCAG GGGCCCCTGGGTGCGGACGGGCGCGGCCAGGAGGGGGTTAAGGCGCAGGCGGCGGCGGGGCGGGGGCGGGCCTGGCGGGCGCCCTCTCCG GGCCCTTTGTTAACAGGCGCGTCCCGGCCAGGCGGAGACGCGGCCGCGGCCATGGGCGGGCGCGGGCGCGCGGGGCGGCGGTGAGGGCGG CTGGCGGGGCCGGGGGCGCCGGGGGGGCGCGCGGGCCGAGCCGGGCCTGAGCCGGGCCCGCGGACCGAGCTGGGAGAGGGGTTCCGGCCC CCGACGTGCTGGCGCGGGAAAATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCCTCCAGCTGT TATCTGGAAGGTTTGCCATCTGCAAATCTGGCCGCACCTAACCTCACTGTGGAGGAAGGAAAGTCTATCACATTATCCTGTAGTGTGGCA GGTGATCCGGTTCCTAATATGTATTGGGATGTTGGTAACCTGGTTTCCAAACATATGAATGAAACAAGCCACACACAGGGCTCCTTAAGG ATAACTAACATTTCATCCGATGACAGTGGGAAGCAGATCTCTTGTGTGGCGGAAAATCTTGTAGGAGAAGATCAAGATTCTGTCAACCTC ACTGTGCATTTTGCACCAACTATCACATTTCTCGAATCTCCAACCTCAGACCACCACTGGTGCATTCCATTCACTGTGAAAGGCAACCCC AAACCAGCGCTTCAGTGGTTCTATAACGGGGCAATATTGAATGAGTCCAAATACATCTGTACTAAAATACATGTTACCAATCACACGGAG TACCACGGCTGCCTCCAGCTGGATAATCCCACTCACATGAACAATGGGGACTACACTCTAATAGCCAAGAATGAGTATGGGAAGGATGAG AAACAGATTTCTGCTCACTTCATGGGCTGGCCTGGAATTGACGATGGTGCAAACCCAAATTATCCTGATGTAATTTATGAAGATTATGGA ACTGCAGCGAATGACATCGGGGACACCACGAACAGAAGTAATGAAATCCCTTCCACAGACGTCACTGATAAAACCGGTCGGGAACATCTC TCGGTCTATGCTGTGGTGGTGATTGCGTCTGTGGTGGGATTTTGCCTTTTGGTAATGCTGTTTCTGCTTAAGTTGGCAAGACACTCCAAG TTTGGCATGAAAGGTTTTGTTTTGTTTCATAAGATCCCACTGGATGGGTAGCTGAAATAAAGGAAAAGACAGAGAAAGGGGCTGTGGTGC TTGTTGGTTGATGCTGCCATGTAAGCTGGACTCCTGGGACTGCTGTTGGCTTATCCCGGGAAGTGCTGCTTATCTGGGGTTTTCTGGTAG ATGTGGGCGGTGTTTGGAGGCTGTACTATATGAAGCCTGCATATACTGTGAGCTGTGATTGGGGAACACCAATGCAGAGGTAACTCTCAG GCAGCTAAGCAGCACCTCAAGAAAACATGTTAAATTAATGCTTCTCTTCTTACAGTAGTTCAAATACAAAACTGAAATGAAATCCCATTG GATTGTACTTCTCTTCTGAAAAGTGTGCTTTTTGACCCTACTGGACATTTATTGACTTAATTGCTTCTGTTTATTAAAATTGACCTGCAA AGTTAAAAAAAAATTAAAGTTGAGAACAGGTATAAGTGCACACTGAATAGTCTAATCTACATGTAACACATATTTTAGTGTGATTTTCTA TACTCTAATCAGCACTGAATTCAGAGGGTTTGACTTTTTCATCTATAACACAGTGACTAAAAGAGTTAAGGGTATATATACCATCACTTT GGGACTTGGTAGTATTATTAAAAGGTTATTTCCTTCACTGTCAATAAAAGTCCAAATGTTTAGCTTAGGTCTGAGAGTCAAACAATGTTA AGGATTGTCTTAAAGTTCCTTAGCCAGCAAAACAAAACAAAACAAAACAAACAAATGAAAAACGTTTAAAAAGAAGAAGAAGAAAAAAAA CAAGAACAAGCAGCAACAGCTGTTTTGTTGGGGCTATAGATTTAAGTTAGGCATAGTCAATTTCAGAATAACTAAGAGTGGAATATATGC ATATGGTGAAATTATAACCTTGCCCTTTTTTATTTGCCCTCTGCGATCCACCTGCTTTTTAGAAGTCTGCCGAGTGAGAAGGCCACAGTA TCTCATGCTGTTTGCATTACAGAACTGCAGCTTTTCTACTCTGAAAAGGCCTGGGAGCAGAATGGCTGGCCTGCTGTGAGCAGGAGAGGA GATTCTAAGAAGGATAGTCCCCCCTACAACATACTGTCATACTGCTGGGTTTTCATGGGTAGGAAAGCTTGTCCTGACCCCAGCAGCAAA GAGGTGGCAGGTCGCTAATGAATATATGCTTTATAATGTCCTTCTTCATTGCTGAGAGGGCAGCCTTAGAGCTGTGGATTTCTGCATCCC CCCTGAGTCTGACCCATGGACACCTGTTTCATTCACTTTAGCATCACAGTGACCTTTGTATGCTCTGTTCAGTCTGTGTCAGGCAGTATG CTTGTCCTGAAGAGAGGTTTGGCTATCCCCACCCCACCCCACCCCACCCTGTTCCTTTTTTATCAGGAGGACTTCAGAGCCAGGCCTGCA GCATTTTGTTTGAAAACACAATCAGCTCTGACAGTTAGACATGCACACAGACGCCATAGCTGGATTGGAAACATTGATGTTTTAAAAATT TATTTTTTTTGGAAATAGTTGCACAAATGCTGCAATTTAGCTTTAAGGTTCTATAGATTTTTAACTAGTCCAACACAGTCAGAAACATTG TTTTGAATCCTCTGTAAACCAAGGCATTAATCTTAATAAACCAGGATCCATTTAGGTACCACTTGATATAAAAAGGATATCCATAATGAA TATTTTATACTGCATCCTTTACATTAGCCACTAAATACGTTATTGCTTGATGAAGACCTTTCACAGAATCCTATGGATTGCAGCATTTCA CTTGGCTACTTCATACCCATGCCTTAAAGAGGGGCAGTTTCTCAAAAGCAGAAACATGCCGCCAGTTCTCAAGTTTTCCTCCTAACTCCA TTTGAATGTAAGGGCAGCTGGCCCCCAATGTGGGGAGGTCCGAACATTTTCTGAATTCCCATTTTCTTGTTCGCGGCTAAATGACAGTTT CTGTCATTACTTAGATTCCGATCTTTCCCAAAGGTGTTGATTTACAAAGAGGCCAGCTAATAGCAGAAATCATGACCCTGAAAGAGAGAT GAAATTCAAGCTGTGAGCCAGGCAGGAGCTCAGTATGGCAAAGGTTCTTGAGAATCAGCCATTTGGTACAAAAAAGATTTTTAAAGCTTT TATGTTATACCATGGAGCCATAGAAAGGCTATGGATTGTTTAAGAACTATTTTAAAGTGTTCCAGACCCAAAAAGGAAAAATAAAAAAAA AGGAATATTTGTACCCAACAGCTAGAAGGATTGCAAGGTAGATTTTTGTTTTAAAATGGAGAGAAGTGGACAGATAAGGCCATTTAATAT ATCAAAGATCAGTTGACATCTCCTAGGGAATGATGAAAACAGCAGGCTATTAGAAAATTATTTCATATAGTTCTCGTGTTCTTTTCTTTT TTTTAATCCCTGAAGGGATGATCAGTAACATAGCTTCTCTTTTCTGTACTCTAGACCACCCCTTTTCATCATTTTGCTTTTTATGTCTCC CATAAGAAATGTGCTTTTTAGAGCTTCCTAATGCATGTGTTGCATTATTGCAGCATTAGAAAAGGAGAGGTAGCATTTTTGCTGAAATCG GGCCTGTCACTCTCCAATAAAGGTTCTGGCACTTCAATGCCAGGCAGGTCTCCTAAATGAACAGAATGATCTGTGTGAGCCGATGCCTGC CCTTCCAGAGGGGCCACTGTCCCCAGCCGCAGCCAACTGTGTCCCACAGGAATGGGAGCCTAGGTTTCCAAATCTTGTGATTCTTTAGGA GAAACATGAAACCTGGATTTCGTGTGAAATGTCCCGATTGTTAAAAAGTTGGCTCAATTATTTTTAAAACATTTTGTAAGCCAACAAAAG TCTGTGGGCTGCCAGTTTATTACTTTTGTCTTAAAACATGATCATTGTTCTCTCACGGTATCCTTCTGTCTTCCCGTTGCAAATTCACTT TTCTTTCTTCCTGACATTGCCATTGAGGGCTTTGTTACCACAAGCTAAGAAACTGAGTTTAACAGCCCAGTTATCTGCAACATGTCAATT ACCTTTGCTCCTCTCCTGTGATTCCCACCATGCTGTGACCCTCAGCTGTCTCCCTTTGCTGGGAATTCTGCACCAATGTCTCCCCTCAAC CCATTCCCTGGTTGGTCCTACTCCCGTGTGGCCAGAGACATCCTAGCAAATCCTTCCTCCTATTATATCTGACACTAATTTCTTTTCAAC AGCGCTCATGTCTCTTGGCCCAGTCAGGTGCTGCCAGGTTTAGATAGGAAAGTACATGTCCCATTTTCATGGGTGCCCTTAATGTGGTCC ACGTCCTATATCTTATTATATTTACTCATGGCTCAATGGGGGCCTCCAGAGACCCTCTCAGGCTGCTGAGCTAGACTAAGGAATGCATCC ACCGTCATCACATGAGACACTGACTCTGTGACGACAAAAGTACAAACAGTCTGAGGCTAAGAAAGGTTCATCTCACAACAGGAAAAACAA ATCTCAACACACATTAGAGATAATTGATTCAGGGGTTTTCTCTCCCAGTCTCCCAGCAGGGACTGATTTCATTTCTGACCCACTAGGTTT TCTTTCCAGAAATAGGTAGCAAGGACAAGAACTAAACAATCCCAGCCCCACCCAGCAACACAGAACACAGGAGTTTGCTTTTGGCTTCTC ACTCTCCAAGTAACCCTGAATTAGGCCCAGAATGGCTGAGGCTTGGAGCATCTCCTCAGACAGAGCAGAGGCGACACCTCTTCAGGGGTG TGTGGAGTAAATAGCTCGAAGAGCTGAAGACAGAAAACCAGTTTCACGCCAGGTGCGAGAGAGAGCATAATGGAGGGAAGCCCGCTTTCT CTCTCCTCTTCTTTTCTCTTTATTTCTTTAGAGCACTTGACTTTTTTTTCTCTCTCTCTCTAGTATTCTAAACTGACCCCATGACCAACT GAGAATTTATTTTTGTTTCATTGGTTGTTTCACAGAATTAGAACACACACGACTTTTTATTCCTCCATTGCAAAATGGAATCAAGATACT ACACAAGACCTGTGCTTTCTTCCTTTGCATGATTTACACCTCCGCCTGTTTTGGTGCTAGCTGTCTAGAACTTCTCTCTTGGTTTGAATC TGATTCCTTCACACTACACTAGAAGTTTATTTCATCTTGTTTTGTCTAGACTCCAGATACAGAGGGACAGCTGGACTGAGGACAAGCAAT TCCATCTAGCATAGGGTCTCTCAGGGTTGGTGCATCCAGCCACATGGGCAGGGCCAGTCACATCTAGTCTATGTCCCCAGAGCCCTTGGA GTTGCGCAGCTTAGCTGACTTGACTCCAAGGAAATTAGTACAGAAGTAACCACTCTATTAAGTGTGTTCTGCTATGTTCACATGCCTGTA GTACCTGCAAACCATGCCAGGTTCATCTAAAGACATAGGGGAAGATTAAGGACTCTTTTGGACAGACCATGAATTGAATTTGCTGCCAGG TGCTGCCAGACTGAATTTGGCTGACAGAACTCCCAGCCCAGGAAAGTTCCATGACAATGACTGTCGCAGAAGGAAATTTCCCACTAAAGT CAGTCCATTTTCAAGTTTTGGTCTTCAGAGACAAAAGAACGTCCCAGCCACCTGATTTTGATGGTGAGGTAACTCTAAGTTGAATTCAGG CTAGTGTTGCAGTATAGCTTTGGCATGTTCATGAGTGAGCACCCAGAATGTGTTGAACCAACCCCCACCCCTAACTACTGACTATGACTG CAGTGGGTTTTTATGGGGAAAAAAAGTGTGAAAAGCAAAAAGAAAGGAACAGAGATTTTTTATCACCTTTATTGTAAGACAGTCCATTTA TGAATTGAGTATAAACACATACAAAGTAACAAGAGATTCCTAAGAAACGCAAATCCTTGAGTTTCACGCACTTCATGTTCAACCATTTGC TGTAATCCAGAGGCAGCCTGTGAATCATTCTCATGCCCTGTTTTTTTTTTTTTTTTCCTATAATGTTCTGGGTTTAAAAGCCATCTTTTC CACATTTTCTGTAAATAATGGATAATCATTTTAAAAATTTTTATTTTTAGTGCTGTTTTAACAATGTAGATAGATCATAAATGTACTTGC >490_490_9_ABL1-NTRK2_ABL1_chr9_133710912_ENST00000318560_NTRK2_chr9_87338487_ENST00000395882_length(amino acids)=346AA_BP=63 MAGPGAPGGRAGRAGPEPGPRTELGEGFRPPTCWRGKMLEICLKLVGCKSKKGLSSSSSCYLEGLPSANLAAPNLTVEEGKSITLSCSVA GDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNP KPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ABL1-NTRK2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000277120 | 5 | 19 | 455_466 | 194.33333333333334 | 839.0 | MAPK8IP3/JIP3 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000304053 | 5 | 15 | 455_466 | 194.33333333333334 | 554.0 | MAPK8IP3/JIP3 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000323115 | 4 | 17 | 455_466 | 194.33333333333334 | 823.0 | MAPK8IP3/JIP3 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000359847 | 4 | 12 | 455_466 | 194.33333333333334 | 478.0 | MAPK8IP3/JIP3 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376208 | 5 | 14 | 455_466 | 194.33333333333334 | 538.0 | MAPK8IP3/JIP3 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376213 | 7 | 20 | 455_466 | 194.33333333333334 | 823.0 | MAPK8IP3/JIP3 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000376214 | 7 | 21 | 455_466 | 194.33333333333334 | 839.0 | MAPK8IP3/JIP3 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395866 | 4 | 12 | 455_466 | 38.333333333333336 | 322.0 | MAPK8IP3/JIP3 | |
Tgene | NTRK2 | chr9:133710912 | chr9:87338487 | ENST00000395882 | 5 | 13 | 455_466 | 194.33333333333334 | 478.0 | MAPK8IP3/JIP3 |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ABL1-NTRK2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | ABL1 | P00519 | DB00619 | Imatinib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB00619 | Imatinib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB00619 | Imatinib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB06616 | Bosutinib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB06616 | Bosutinib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB06616 | Bosutinib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | ABL1 | P00519 | DB01254 | Dasatinib | Multitarget | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB01254 | Dasatinib | Multitarget | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB01254 | Dasatinib | Multitarget | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB04868 | Nilotinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB04868 | Nilotinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB04868 | Nilotinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB12267 | Brigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB12267 | Brigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | ABL1 | P00519 | DB12267 | Brigatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | NTRK2 | Q16620 | DB00321 | Amitriptyline | Agonist | Small molecule | Approved |
Tgene | NTRK2 | Q16620 | DB00321 | Amitriptyline | Agonist | Small molecule | Approved |
Tgene | NTRK2 | Q16620 | DB11823 | Esketamine | Small molecule | Approved|Investigational | |
Tgene | NTRK2 | Q16620 | DB11823 | Esketamine | Small molecule | Approved|Investigational | |
Tgene | NTRK2 | Q16620 | DB11986 | Entrectinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | NTRK2 | Q16620 | DB11986 | Entrectinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | NTRK2 | Q16620 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | NTRK2 | Q16620 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | NTRK2 | Q16620 | DB14723 | Larotrectinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | NTRK2 | Q16620 | DB14723 | Larotrectinib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for ABL1-NTRK2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ABL1 | C0023473 | Myeloid Leukemia, Chronic | 3 | CGI;CTD_human;ORPHANET |
Hgene | ABL1 | C0023452 | Childhood Acute Lymphoblastic Leukemia | 2 | CTD_human |
Hgene | ABL1 | C0023453 | L2 Acute Lymphoblastic Leukemia | 2 | CTD_human |
Hgene | ABL1 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2 | CGI;CTD_human |
Hgene | ABL1 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | ABL1 | C0003706 | Arachnodactyly | 1 | GENOMICS_ENGLAND |
Hgene | ABL1 | C0005941 | Bone Diseases, Developmental | 1 | CTD_human |
Hgene | ABL1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Hgene | ABL1 | C0006413 | Burkitt Lymphoma | 1 | ORPHANET |
Hgene | ABL1 | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
Hgene | ABL1 | C0015544 | Failure to Thrive | 1 | CTD_human |
Hgene | ABL1 | C0018798 | Congenital Heart Defects | 1 | CTD_human |
Hgene | ABL1 | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | ABL1 | C0027659 | Neoplasms, Experimental | 1 | CTD_human |
Hgene | ABL1 | C0032927 | Precancerous Conditions | 1 | CTD_human |
Hgene | ABL1 | C0039075 | Syndactyly | 1 | GENOMICS_ENGLAND |
Hgene | ABL1 | C0151491 | Congenital musculoskeletal anomalies | 1 | CTD_human |
Hgene | ABL1 | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
Hgene | ABL1 | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
Hgene | ABL1 | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
Hgene | ABL1 | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
Hgene | ABL1 | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
Hgene | ABL1 | C0265610 | Clinodactyly of fingers | 1 | GENOMICS_ENGLAND |
Hgene | ABL1 | C0282313 | Condition, Preneoplastic | 1 | CTD_human |
Hgene | ABL1 | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Hgene | ABL1 | C0546837 | Malignant neoplasm of esophagus | 1 | CTD_human |
Hgene | ABL1 | C0596263 | Carcinogenesis | 1 | CTD_human |
Hgene | ABL1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Hgene | ABL1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Hgene | ABL1 | C1292769 | Precursor B-cell lymphoblastic leukemia | 1 | ORPHANET |
Hgene | ABL1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | ABL1 | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | CGI;ORPHANET |
Hgene | ABL1 | C4539857 | CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME | 1 | GENOMICS_ENGLAND;UNIPROT |
Hgene | ABL1 | C4551485 | Clinodactyly | 1 | GENOMICS_ENGLAND |
Hgene | ABL1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Tgene | C0011570 | Mental Depression | 5 | PSYGENET | |
Tgene | C0011581 | Depressive disorder | 5 | PSYGENET | |
Tgene | C0041696 | Unipolar Depression | 5 | PSYGENET | |
Tgene | C0525045 | Mood Disorders | 5 | PSYGENET | |
Tgene | C1269683 | Major Depressive Disorder | 5 | PSYGENET | |
Tgene | C3151303 | Obesity, Hyperphagia, and Developmental Delay | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0005586 | Bipolar Disorder | 3 | CTD_human;PSYGENET | |
Tgene | C4693367 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58 | 3 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0009171 | Cocaine Abuse | 2 | CTD_human | |
Tgene | C0036341 | Schizophrenia | 2 | PSYGENET | |
Tgene | C0038220 | Status Epilepticus | 2 | CTD_human | |
Tgene | C0236736 | Cocaine-Related Disorders | 2 | CTD_human | |
Tgene | C0270823 | Petit mal status | 2 | CTD_human | |
Tgene | C0311335 | Grand Mal Status Epilepticus | 2 | CTD_human | |
Tgene | C0393734 | Complex Partial Status Epilepticus | 2 | CTD_human | |
Tgene | C0600427 | Cocaine Dependence | 2 | CTD_human | |
Tgene | C0751217 | Hyperkinesia, Generalized | 2 | CTD_human | |
Tgene | C0751522 | Status Epilepticus, Subclinical | 2 | CTD_human | |
Tgene | C0751523 | Non-Convulsive Status Epilepticus | 2 | CTD_human | |
Tgene | C0751524 | Simple Partial Status Epilepticus | 2 | CTD_human | |
Tgene | C3887506 | Hyperkinesia | 2 | CTD_human | |
Tgene | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET | |
Tgene | C0004114 | Astrocytoma | 1 | CTD_human | |
Tgene | C0004352 | Autistic Disorder | 1 | CTD_human | |
Tgene | C0005587 | Depression, Bipolar | 1 | CTD_human | |
Tgene | C0008073 | Developmental Disabilities | 1 | CTD_human | |
Tgene | C0013415 | Dysthymic Disorder | 1 | PSYGENET | |
Tgene | C0017638 | Glioma | 1 | CTD_human | |
Tgene | C0020505 | Hyperphagia | 1 | CTD_human | |
Tgene | C0024713 | Manic Disorder | 1 | CTD_human | |
Tgene | C0027819 | Neuroblastoma | 1 | CTD_human | |
Tgene | C0028754 | Obesity | 1 | CTD_human | |
Tgene | C0036349 | Paranoid Schizophrenia | 1 | PSYGENET | |
Tgene | C0037769 | West Syndrome | 1 | ORPHANET | |
Tgene | C0085996 | Child Development Deviations | 1 | CTD_human | |
Tgene | C0085997 | Child Development Disorders, Specific | 1 | CTD_human | |
Tgene | C0205768 | Subependymal Giant Cell Astrocytoma | 1 | CTD_human | |
Tgene | C0259783 | mixed gliomas | 1 | CTD_human | |
Tgene | C0280783 | Juvenile Pilocytic Astrocytoma | 1 | CTD_human | |
Tgene | C0280785 | Diffuse Astrocytoma | 1 | CTD_human | |
Tgene | C0334579 | Anaplastic astrocytoma | 1 | CTD_human | |
Tgene | C0334580 | Protoplasmic astrocytoma | 1 | CTD_human | |
Tgene | C0334581 | Gemistocytic astrocytoma | 1 | CTD_human | |
Tgene | C0334582 | Fibrillary Astrocytoma | 1 | CTD_human | |
Tgene | C0334583 | Pilocytic Astrocytoma | 1 | CTD_human | |
Tgene | C0338070 | Childhood Cerebral Astrocytoma | 1 | CTD_human | |
Tgene | C0338831 | Manic | 1 | CTD_human | |
Tgene | C0547065 | Mixed oligoastrocytoma | 1 | CTD_human | |
Tgene | C0555198 | Malignant Glioma | 1 | CTD_human | |
Tgene | C0678807 | prenatal alcohol exposure | 1 | PSYGENET | |
Tgene | C0750935 | Cerebral Astrocytoma | 1 | CTD_human | |
Tgene | C0750936 | Intracranial Astrocytoma | 1 | CTD_human | |
Tgene | C0752347 | Lewy Body Disease | 1 | CTD_human | |
Tgene | C1519086 | Pilomyxoid astrocytoma | 1 | ORPHANET | |
Tgene | C1704230 | Grade I Astrocytoma | 1 | CTD_human | |
Tgene | C3146244 | Alcohol Related Birth Defect | 1 | PSYGENET |